MedMira Inc. Stock price

Equities

MIR

CA58501R1029

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. 02:01:31 2024-03-28 pm EDT 5-day change 1st Jan Change
0.085 CAD 0.00% Intraday chart for MedMira Inc. 0.00% -22.73%
Sales 2022 952K 702K Sales 2023 433K 319K Capitalization 59.28M 43.72M
Net income 2022 -1M -738K Net income 2023 -2M -1.48M EV / Sales 2022 101 x
Net Debt 2022 8.77M 6.46M Net Debt 2023 10.03M 7.4M EV / Sales 2023 160 x
P/E ratio 2022
-41.7 x
P/E ratio 2023
-21.3 x
Employees 52
Yield 2022 *
-
Yield 2023
-
Free-Float 29.3%
More Fundamentals * Assessed data
Dynamic Chart
Current month-10.53%
1 month-10.53%
3 months-22.73%
6 months-10.53%
Current year-22.73%
More quotes
1 week
0.08
Extreme 0.08
0.09
1 month
0.08
Extreme 0.08
0.10
Current year
0.08
Extreme 0.08
0.12
1 year
0.08
Extreme 0.075
0.14
3 years
0.05
Extreme 0.05
0.28
5 years
0.00
Extreme 0
0.89
10 years
0.00
Extreme 0
0.89
More quotes
Managers TitleAgeSince
Founder - 92-12-31
Director of Finance/CFO - 10-01-27
Director/Board Member 60 07-04-30
Members of the board TitleAgeSince
Founder - 92-12-31
Director/Board Member 60 07-04-30
Director of Finance/CFO - 10-01-27
More insiders
Date Price Change Volume
24-03-28 0.085 0.00% 11,500
24-03-27 0.085 +6.25% 56,000
24-03-26 0.08 -5.88% 22,120
24-03-25 0.085 -5.56% 87,933
24-03-22 0.09 +5.88% 5,500

Delayed Quote Toronto S.E., March 28, 2024 at 02:01 pm EDT

More quotes
MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.
More about the company
  1. Stock
  2. Equities
  3. Stock MedMira Inc. - Toronto S.E.